15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 2 firms covering Pmv Pharmaceuticals Inc, 2 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets span $3.00 to $5.00, a moderate spread. The average target of $4.00 sits 264% above the current $1.10. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 1 to 2 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.35 next quarter toward $-1.09 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS2 ratings
Moderate Buy
Strong Buy00%
Buy2100%
Hold00%
Sell00%
Strong Sell00%
Based on 2 analysts giving stock ratings to Pmv Pharmaceuticals Inc.
As of Jul, 2 of 2 firms rate PMVP a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
PMVP EPS & revenue forecast
EPS · NEXT QUARTER
$-0.35
Range $-0.40 – $-0.27 · 3 analysts · -12% YoY
Next period, 3 analysts expect Pmv Pharmaceuticals Inc to earn $-0.35 a share (range $-0.40 – $-0.27), versus $-0.40 a year earlier. Full-year consensus is $-1.51, growing to $-1.09 the year after.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 3 analysts
Revenue is expected to reach $0 (range $0 – $0). Full-year consensus is $0, rising to $3.2M next year.
Top analysts covering Pmv Pharmaceuticals Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on PMVP.
#1
RB
Robert Burns
HC Wainwright & Co. · Rank #195
Buy
$5.00+354.5% to target
Overall win rate
38%
+ Follow
#2
Jeff Jones
Oppenheimer · Rank #197
Buy
$5.00+354.5% to target
Overall win rate
34%
+ Follow
#3
AL
Albert Lowe
Craig-Hallum
Buy
$4.00+263.6% to target
Coverage
—
+ Follow
PMVP stock forecast FAQ
What is PMVP's average 12-month price target?+
The 1 analysts with a live target average $4.00 for Pmv Pharmaceuticals Inc over the next 12 months, ranging from a $5.00 high to a $3.00 low.
Is PMVP stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 2 analyst ratings, 2 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for PMVP?+
The Street-high target is $5.00 (Oppenheimer), and the Street-low is $3.00. The average of all 1 active targets is $4.00.
How many Wall Street analysts cover PMVP?+
2 analysts have an active rating on Pmv Pharmaceuticals Inc, and 1 firms carry a live 12-month price target.
Who is the most accurate analyst covering PMVP?+
Among analysts who currently cover PMVP, Robert Burns of HC Wainwright & Co. has the strongest overall Quantellect track record (Rank #195). Their current call is Buy with a $5.00 target.
What is Pmv Pharmaceuticals Inc's projected EPS for next quarter?+
The consensus estimate is $-0.35 per share (range $-0.40 – $-0.27) across 3 analysts. Full-year EPS is projected at $-1.51, rising to $-1.09 the following year.
How much revenue is Pmv Pharmaceuticals Inc expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0). Full-year revenue is projected at $0, growing to $3.2M next year.
Have analysts been upgrading or downgrading PMVP lately?+
As of Jul, 2 of 2 firms rate PMVP a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their PMVP calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
